BioNano Genomics, Inc. (BNGO) Reports Q4 Net Loss of $29.5M

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 net loss of $29.5M. Revenue for the quarter came in at $6.3 million versus the consensus estimate of $5.57 million.

GUIDANCE:

BioNano Genomics, Inc. sees FY2022 revenue of $24-27 million.

For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04